Perspectives from those who live it every day.
In this On Target podcast, Dr Akila Viswanathan and the COVID-19 response team from the Department of Radiation Oncology and Molecular Radiations Sciences provide an update on our response to the COVID-19 pandemic.
In the latest Cancer Matters podcast, Dr Bill Nelson speaks with Dr Bert Vogelstein about shifting his work as a cancer researcher to detecting and preventing the spread of COVID-19.
In this Cancer Matters podcast, Dr Bill Nelson and Dr Otis Brawley discuss why the poor and disadvantaged that are already struggling with a cancer diagnosis are also more susceptible to COVID-19.
Researchers in the Ludwig Center at the Johns Hopkins Kimmel Cancer Center report they have identified a drug treatment that could—if given early enough—potentially reduce the risk of death from the most serious complication of Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 infection. Read the full news release
The Cancer Matters podcast returns with Dr Bill Nelson and Dr Carol Ann Huff explaining how the Johns Hopkins Kimmel Cancer Center is handling the COVID-19 pandemic and adjusting to treat patients who contract the virus.
In this special edition of the On Target podcast, Dr Akila Viswanathan speaks with members of the Johns Hopkins Radiation Oncology COVID-19 response team about the protocols and patient procedures implemented throughout Johns Hopkins Medicine to ensure cancer patients continue to receive their care and remain safe from the Coronavirus.